Sequoia Financial Advisors LLC Sells 2,584 Shares of Danaher Corporation (NYSE:DHR)

Sequoia Financial Advisors LLC lessened its holdings in shares of Danaher Corporation (NYSE:DHRFree Report) by 11.6% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 19,735 shares of the conglomerate’s stock after selling 2,584 shares during the quarter. Sequoia Financial Advisors LLC’s holdings in Danaher were worth $4,046,000 at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. Heck Capital Advisors LLC bought a new stake in shares of Danaher during the 4th quarter valued at about $27,000. GHP Investment Advisors Inc. boosted its position in shares of Danaher by 396.0% during the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock valued at $25,000 after acquiring an additional 99 shares during the last quarter. Hurley Capital LLC bought a new stake in shares of Danaher during the 4th quarter valued at about $34,000. Rialto Wealth Management LLC bought a new stake in shares of Danaher during the 4th quarter valued at about $34,000. Finally, Dunhill Financial LLC boosted its position in shares of Danaher by 68.4% during the 1st quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate’s stock valued at $34,000 after acquiring an additional 67 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.

Analysts Set New Price Targets

DHR has been the subject of a number of recent research reports. JPMorgan Chase & Co. dropped their target price on Danaher from $280.00 to $260.00 and set an “overweight” rating for the company in a research report on Tuesday, April 22nd. Argus dropped their target price on Danaher from $260.00 to $240.00 in a research report on Wednesday, April 23rd. TD Cowen boosted their target price on Danaher from $240.00 to $248.00 and gave the stock a “buy” rating in a research report on Wednesday, April 23rd. Robert W. Baird dropped their target price on Danaher from $231.00 to $225.00 and set an “outperform” rating for the company in a research report on Wednesday, April 23rd. Finally, Bank of America dropped their target price on Danaher from $265.00 to $230.00 in a research report on Monday, April 14th. Four equities research analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $248.61.

Check Out Our Latest Stock Analysis on DHR

Insider Buying and Selling

In other news, Chairman Steven M. Rales sold 1,250,000 shares of the stock in a transaction on Monday, May 12th. The stock was sold at an average price of $196.74, for a total value of $245,925,000.00. Following the sale, the chairman now directly owns 3,105,808 shares of the company’s stock, valued at approximately $611,036,665.92. This represents a 28.70% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Christopher Paul Riley sold 15,805 shares of the firm’s stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total value of $3,129,390.00. Following the transaction, the executive vice president now owns 15,179 shares of the company’s stock, valued at $3,005,442. The trade was a 51.01% decrease in their ownership of the stock. The disclosure for this sale can be found here. 11.10% of the stock is owned by insiders.

Danaher Price Performance

DHR opened at $198.20 on Friday. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.43. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $281.70. The stock has a market capitalization of $141.84 billion, a PE ratio of 38.48, a price-to-earnings-growth ratio of 2.83 and a beta of 0.77. The stock’s 50 day moving average price is $194.84 and its 200-day moving average price is $208.52.

Danaher (NYSE:DHRGet Free Report) last posted its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.62 by $0.26. Danaher had a return on equity of 10.80% and a net margin of 15.81%. The firm had revenue of $5.74 billion for the quarter, compared to analysts’ expectations of $5.58 billion. On average, equities research analysts predict that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be paid a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.65%. Danaher’s payout ratio is 24.85%.

Danaher Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Further Reading

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.